N/A
Completed N=70
DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance
Source: ClinicalTrials.gov NCT02403180 ↗Enrolled (actual)
70
Serious AEs
0.0%
Results posted
Aug 2016
Primary outcomePrimary: Mean Stereoacuity at Near After 5+/-1 Days of Contact Lens Wear — 40.6; 30.7 arcsec
Summary
The purpose of this study is to evaluate the visual performance of DACP MF and PROCLEAR 1D MF daily disposable contact lenses in an established presbyopic population.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Stereoacuity at Near After 5+/-1 Days of Contact Lens Wear |
40.6; 30.7 | — |
| SECONDARY Mean Area of Focus Under the Mean Defocus Curve After 5 +/- 1 Days of Contact Lens Wear |
0.04; 0.07; 0.17; 0.21 | — |
Eligibility Criteria
Inclusion Criteria
- Must sign an informed consent;
- Adapted soft contact lens wearer;
- Vision correctable to 20/30 [(0.2 logMAR (logarithm of the minimum angle of resolution)] or better in each eye at distance;
- Willing to wear lenses every day or for at least 5 days per week, 6 hours per day;
- Other protocol-specified inclusion criteria may apply.
Exclusion Criteria
- Currently wearing multifocal contact lenses;
- Currently wearing monovision;
- Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear;
- Use of systemic or ocular medications which could contraindicate contact lens wear;
- Eye injury or surgery within 12 weeks prior to enrollment;
- Prior refractive surgery;
- Monocular (only 1 eye with functional vision) or fit with only 1 lens;
- Other protocol-specified exclusion criteria may apply.
Data sourced from ClinicalTrials.gov (NCT02403180). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.